Repository logo

FCS - Artigos em Atas de Conferências Internacionais

Permanent URI for this collection

http://hdl.handle.net/10284/2129

Browse

Browsing FCS - Artigos em Atas de Conferências Internacionais by Subject "Brain delivery"

Now showing 1 - 1 of 1
  • Permeability assay and inflammatory marker quantification of lactoferrin functionalized lipid nanoparticles intended for brain delivery
    Publication . Teixeira, Maria Inês; Lopes, Carla Martins; Reguengo, Henrique; Oliveira, José Carlos; Silva, Ana Margarida; Rodrigues, Francisca; Amaral, Maria Helena; Costa, Paulo C.
    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a survival rate of 3 to 5 years from the onset of symptoms. ALS treatment is compromised by the existence of the blood-brain barrier (BBB), which restricts the access of promising biopharmaceutics to the brain, including riluzole, a drug commonly used to treat ALS. To circumvent the BBB and improve the drug brain targeting, nanosystems such as lipid nanoparticles can be employed. In this work, the permeation of nanostructured lipid carriers (NLC) loaded with riluzole and functionalized with a specific ligand – lactoferrin – was assessed in an in vitro BBB model (hCMEC/D3 cell line). Moreover, the effect of the NLC on the production and secretion of the pro-inflammatory cytokine human interleukin 1 alpha (IL-1a) by the cells was also quantified. The permeability studies across the hCMEC/D3 cell monolayers showed that free riluzole penetrated the BBB more than the riluzole-loaded NLC, which was also consistent with the results from the ELISA kit, with the free drug eliciting a higher IL-1a production. Despite these findings, the developed nanocarriers possessed good biocompatibility and stability, and could, therefore, be considered suitable for brain applications.
    2022Conference object Restricted access Show more